Search results for "Psoriasis."

showing 10 items of 191 documents

An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling

2013

Topical application of imiquimod (IMQ) on the skin of mice induces inflammation with common features found in psoriatic skin. Recently, it was postulated that IL-17 has an important role both in psoriasis and in the IMQ model. To further investigate the impact of IL-17RA signaling in psoriasis, we generated IL-17 receptor A (IL-17RA)-deficient mice (IL-17RA(del)) and challenged these mice with IMQ. Interestingly, the disease was only partially reduced and delayed but not abolished when compared with controls. In the absence of IL-17RA, we found persisting signs of inflammation such as neutrophil and macrophage infiltration within the skin. Surprisingly, already in the naive state, the skin …

ChemokineInflammationImiquimodDermatologyInterleukin-17 receptorBiochemistryMiceAdjuvants ImmunologicPsoriasismedicineAnimalsPsoriasisMacrophageMolecular BiologySkinMice KnockoutImiquimodReceptors Interleukin-17biologyInterleukin-6InterleukinsMacrophagesInterleukin-17Cell Biologymedicine.diseaseDisease Models AnimalCXCL2Neutrophil InfiltrationImmunologyAminoquinolinesbiology.proteinFemaleTumor necrosis factor alphamedicine.symptomSignal Transductionmedicine.drugJournal of Investigative Dermatology
researchProduct

Comparison of DNase, DNA-polymerase and RNA-polymerase activities present in the DNA-bindung proteins of normal human dermis, epidermis, horny layer …

1978

DNA-binding proteins (DBP) of normal human dermis, epidermis, horny layer and psoriatic scales represent a tissue-specific group of mostly nuclear nonhistone proteins. To analyse their function, the different DBP fractions were examined concerning the presence of DNase, DNA-polymerase and RNA-polymerase activities. DBP of normal epidermis and horny layer contain four different DNases. One DNase of both DBP fractions is active only at pH 5.0. Three DNases of epidermal DBP are active at a pH-range from 5.0--8.5, while the corresponding DNases of horny layer-DBP are most active at pH 7.4. Probably these DNases have changed their pH-optimum during keratinisation. DBP of psoriatic scales include…

DNA polymeraseDNA-Directed DNA PolymeraseDermatologychemistry.chemical_compoundNon-histone proteinDermisRNA polymerasemedicineHumansPsoriasisSkinchemistry.chemical_classificationThymidine monophosphateDeoxyribonucleasesEpidermis (botany)biologyIsoelectric focusingProteinsDNA-Directed RNA PolymerasesGeneral MedicineElectrophoresis DiscMolecular biologyEnzyme Activationmedicine.anatomical_structureEnzymechemistrybiology.proteinEpidermisIsoelectric FocusingProtein Bindingcirculatory and respiratory physiologyArchives of Dermatological Research
researchProduct

Separation of deoxyribonucleases (DNases) of normal human stratum corneum and psoriatic scales by micro-disc-electrophoresis.

1975

Normal stratum corneum and psoriatic scales were homogenized and a differential centrifugation was performed. The DNase activity of the individual fractions was investigated by micro-disc-electrophoresis. At pH 5 only in the 600 × g pellet and 105.000 × g supernatant of normal keratin DNase activity could be observed. However, all psoriatic fractions showed distinct enzyme activities. At pH 7.4 little psoriatic DNase activity could only be demonstrated in the 105.000 × g supernatant. Except from the 15.000 × g pellet all fractions of normal stratum corneum displayed marked activities. In addition the 105.000 × g supernatant showed two different DNase bands.

DermatologyKeratinStratum corneummedicineHumansPsoriasisCentrifugationPolyacrylamide gel electrophoresisSkinDifferential centrifugationchemistry.chemical_classificationChromatographyDeoxyribonucleasesintegumentary systembiologyChemistryGeneral MedicineHydrogen-Ion ConcentrationEnzyme assayIsoenzymesMolecular WeightElectrophoresismedicine.anatomical_structurebiology.proteinElectrophoresis Polyacrylamide GelDeoxyribonucleasesSubcellular FractionsArchives for dermatological research = Archiv fur dermatologische Forschung
researchProduct

Consideraciones en el diagnóstico de psoriasis oral: Presentación de un caso clínico

2004

Este artículo comenta las dificultades de hacer un diagnóstico definitivo de psoriasis oral basado en la evidencia clínica e histológica. Se presenta un joven varón negro con múltiples lesiones que muestran erosiones, fisuras y escaras amarillentas en el borde bermellón de ambos labios. También tenía áreas eritematosas-erosivas en la encía, una lengua fisurada que mostraba áreas grisáceas en su superficie ventral, lesiones blanquecinas y lesiones longitudinales en el paladar duro junto lesiones entrelazadas en el paladar blando. Las biopsias del labio inferior , la encía y el paladar blando mostraron hiperqueratosis, espongiosis, acantosis, y elongación de las crestas epiteliales. Además, s…

DiagnósticoUNESCO::CIENCIAS MÉDICASOdontologíalesiones oraleslesiones psoriasiformes oralespsoriasis:CIENCIAS MÉDICAS [UNESCO]Ciencias de la salud
researchProduct

Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles

2021

Atopic dermatitis (AD) and psoriasis are the most common chronic inflammatory skin disorders, which importantly affect the quality of life of patients who suffer them. Among other causes, nitric oxide has been reported as part of the triggering factors in the pathogenesis of both conditions. Cyanocobalamin (vitamin B12) has shown efficacy as a nitric oxide scavenger and some clinical trials have given positive outcomes in its use for treating skin pathologies. Passive skin diffusion is possible only for drugs with low molecular weights and intermediate lipophilicity. Unfortunately, the molecular weight and hydrophilicity of vitamin B12 do not predict its effective diffusion through the skin…

Drugliposomesmedia_common.quotation_subjectPharmaceutical Sciencelcsh:RS1-441Dermatitis02 engineering and technologyPharmacology030226 pharmacology & pharmacyArticleNitric oxidelcsh:Pharmacy and materia medica03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePsoriasismedicineCyanocobalaminVitamin B12cyanocobalaminskin topical deliverymedia_commonLiposomeatopic dermatitisVesiclePellAtopic dermatitisvitamin B12psoriasis021001 nanoscience & nanotechnologymedicine.diseaselipid vesicleschemistrytransferosomes0210 nano-technologyTecnologia farmacèuticaPharmaceutics
researchProduct

Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm…

2020

Background and objectives: Current psoriasis guidelines do not usually include recommendations about first line classical or biologic treatment. The objectives of this study were: to describe shifts in the prescription of the first biological treatment, and to compare treatment withdrawal and rates of adverse events over ten years. Material and methods: Biobadaderm registry was analyzed to describe: first biological prescription in bio-naive patients, adverse events rate and reasons for drug withdrawal comparing three periods of time (2008-2010, 2011-2014, 2015-2018). Results: Anti-TNF drugs were the most prescribed biological drug from 2008 to 2010. Ustekinumab has become the most prescrib…

Drugmedicine.medical_specialtyHistologyBiologicmedia_common.quotation_subjectDiscontinuationDermatologyBiologic treatmentPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciencesDrug withdrawal0302 clinical medicinePsoriasisUstekinumabTrendmedicinePsoriasisMedical prescriptionIntensive care medicineAdverse effectmedia_commonbusiness.industryBiobadadermmedicine.diseaseDiscontinuationTreatment030220 oncology & carcinogenesisbusinessmedicine.drug
researchProduct

Pembrolizumab: a new Drug That Can Induce Exacerbations of Psoriasis.

2015

Drugmedicine.medical_specialtyHistologybusiness.industrymedia_common.quotation_subjectMEDLINEDermatologyPembrolizumabAntibodies Monoclonal Humanizedmedicine.diseaseDermatologyPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPsoriasisMonoclonalmedicineHumansPsoriasisbusinessmedia_common
researchProduct

Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microe…

2017

The tumour immune microenvironment is considered to influence cancer behaviour and outcome. Using a panel of markers for innate and adaptive immune cells we set out to characterise and understand the bladder tumour microenvironment of 114 patients from a prospective multicentre cohort of newly-diagnosed bladder cancer patients, followed-up for 4.33±1.71 years. We found IL-17-positive cells were significantly increased in primary and concomitant carcinoma in situ (CIS), p<0.0001, a highly malignant lesion which is the most significant single risk factor for disease progression. Further characterisation of the tumour immunophenotype identified IL-17+ cells as predominantly mast cells rather t…

EXPRESSIONPSORIASISBACILLUS-CALMETTE-GUERINCYTOKINESlcsh:Rlcsh:MedicinePROGRESSIONCOLORECTAL-CANCERIL-17INFLAMMATIONCARCINOMA IN-SITUlcsh:QRECURRENCElcsh:SciencePLoS ONE
researchProduct

Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte–endothelial cell interactions

2015

AbstractEnhanced leukocyte recruitment is an inflammatory process that occurs during early phases of the vascular dysfunction that characterises atherosclerosis. We evaluated the impact of anti-TNF-α (adalimumab, infliximab and etanercept) and anti-IL-12/23 (ustekinumab) on interactions between human leukocytes and endothelial cells in a flow chamber that reproduced in vivo conditions. Clinical concentrations of anti-TNF-α were evaluated on the leukocyte recruitment induced by a variety of endothelial (TNF-α, interleukin-1β, lymphotoxin-α and angiotensin-II) and leukocyte (PAF, IL-12 and IL-23) stimuli related to inflammation and atherosclerosis. Treatment with anti-TNF-α, even before or af…

EndotheliumInflammationAnti-IL-12/23 agentsCardiovascular side effectsBiologicsInterleukin-23Rheumatic diseasesIn vivoPsoriasisHuman Umbilical Vein Endothelial CellsInterleukin 23HumansMedicineAnti-TNF-α agentsPharmacologyTumor Necrosis Factor-alphabusiness.industryCell adhesion moleculeAdalimumabEndothelial Cellsmedicine.diseaseInterleukin-12Leukocyte–endothelial cell interactionsEndothelial stem cellmedicine.anatomical_structureImmunologyLeukocytes MononuclearTumor necrosis factor alphamedicine.symptombusinessEuropean Journal of Pharmacology
researchProduct

P114 A screening tool for the early diagnosis of extraintestinal manifestations in inflammatory bowel disease: the EMAIL questionnaire

2020

Abstract Background Data on prevalence of extraintestinal manifestations (EIMs) in inflammatory bowel disease (IBD) range from 6% up to 47%. Recently, several red flags and questionnaires have been proposed for early diagnosis of articular manifestations. Our aim was to analyse the prevalence of EIMs in a single-centre prospective cohort, using a comprehensive questionnaire developed by our group to detect all EIMs (EMAIL questionnaire). Methods Patients with IBD attending our Clinic from November 2017 to January 2019 were interviewed using a two-part questionnaire, the first part for clinical-demographic data and the second part for EIMs. Patients positive to screening were referred for mu…

Erythema nodosumAnkylosing spondylitismedicine.medical_specialtyCrohn's diseasebusiness.industryGastroenterologySacroiliitisGeneral Medicinemedicine.diseaseUlcerative colitisInflammatory bowel diseaseInternal medicinePsoriasismedicinebusinessPyoderma gangrenosumJournal of Crohn's and Colitis
researchProduct